The effect of substance P on peripheral blood mononuclear cells in patients with atopic dermatitis

Journal of Dermatological Science

Volumn 32, Issue 2, 2003, Pages 115-124

  Kim, Kyu Han ^a   Park, Kyoung Chan ^a   Chung, Jin Ho ^a   Choi, Hae Ryung ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Atopic dermatitis; Cytokine; Proliferation; Substance P; Substance P receptor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; SUBSTANCE P; SUBSTANCE P RECEPTOR;

ADULT; ARTICLE; ATOPIC DERMATITIS; CELL PROLIFERATION; CELL SEPARATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; MEASUREMENT; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 0037824423     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(03)00070-7     Document Type: Article

References (36)

1. Pincelli C., Fantini F., Massimi P., Girolomoni G., Seidenari S., Giannetti A. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br. J. Dermatol. 122:1990;745-750.
2. Ostlere L.S., Cowen T., Rustin M.H. Neuropeptides in the skin of patients with atopic dermatitis. Clin. Exp. Dermatol. 20:1995;462-467.
3. Scholzen T., Armstrong C.A., Bunnett N.W., Luger T.A., Olerud J.E., Ansel J.C. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp. Dermatol. 7:1998;81-96.
4. Tobin D., Nabarro G., Baart de la Faille H., van Vloten W.A., van der Putte S.C., Schuurman H.J. Increased number of immunoreactive nerve fibers in atopic dermatitis. J. Allergy. Clin. Immunol. 90:1992;613-622.
5. Sugiura H., Omoto M., Hirota Y., Danno K., Uehara M. Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch. Dermatol. Res. 289:1997;125-131.
6. Fantini F., Pincelli C., Romualdi P., Donatini A., Giannetti A. Substance P levels are decreased in lesional skin of atopic dermatitis. Exp. Dermatol. 1:1992;127-128.
7. Ansel J.C., Kaynard A.K., Armstrong C.A., Olerud J., Bunnett N., Payan D. Skin-nervous system interactions. J. Invest. Dermatol. 106:1996;198-204.
8. Wagner F., Fink R., Hart R., Dancygier H. Substance P enhances interferon-gamma production by human peripheral blood mononuclear cells. Regul. Pept. 19:1987;355-364.
9. Payan D.G., Brewster D.R., Goetzl E.J. Specific stimulation of human T lymphocytes by substance P. J. Immunol. 131:1983;1613-1615.
10. Pascual D.W., Xu-Amano J.C., Kiyono H., McGhee J.R., Bost K.L. Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production. J. Immunol. 146:1991;2130-2136.
11. Schratzberger P., Reinisch N., Prodinger W.M., Kahler C.M., Sitte B.A., Bellmann R., Fischer-Colbrie R., Winkler H., Wiedermann C.J. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J. Immunol. 158:1997;3895-3901.
12. Lotz M., Vaughan J.H., Carson D.A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science. 241:1988;1218-1221.
13. Laurenzi M.A., Persson M.A., Dalsgaard C.J., Haegerstrand A. The neuropeptide substance P stimulates production of interleukin 1 in human blood monocytes: activated cells are preferentially influenced by the neuropeptide. Scand. J. Immunol. 31:1990;529-533.
14. Lee H.R., Ho W.Z., Douglas S.D. Substance P augments tumor necrosis factor release in human monocyte-derived macrophages. Clin. Diagn. Lab. Immunol. 1:1994;419-423.
15. Ho W.Z., Kaufman D., Uvaydova M., Douglas S.D. Substance P augments interleukin-10 and tumor necrosis factor-alpha release by human cord blood monocytes and macrophages. J. Neuroimmunol. 71:1996;73-80.
16. Kincy-Cain T., Bost K.L. Substance P-induced IL-12 production by murine macrophages. J. Immunol. 158:1997;2334-2339.
17. Nilsson G., Rak S., Ahlstedt S. The influence of substance P on the proliferation of peripheral blood lymphocytes from normal individuals and birch pollen-allergic patients. Allergy. 42:1987;516-523.
18. Yokote R., Yagi H., Furukawa F., Takigawa M. Regulation of peripheral blood mononuclear cell responses to Dermatophagoides farinae by substance P in patients with atopic dermatitis. Arch. Dermatol. Res. 290:1998;191-197.
19. Gordon D.J., Ostlere L.S., Holden C.A. Neuropeptide modulation of Th1 and Th2 cytokines in peripheral blood mononuclear leucocytes in atopic dermatitis and non-atopic controls. Br. J. Dermatol. 137:1997;921-927.
20. Kang H., Byun D.G., Kim J.W. Effects of substance P and vasoactive intestinal peptide on interferon-gamma and interleukin-4 production in severe atopic dermatitis. Ann. Allergy Asthma Immunol. 85:2000;227-232.
21. Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Derm. Venereol. (Stockh.). 92:(Suppl.):1980;44-47.
22. Rajka G., Langeland T. Grading of the severity of atopic dermatitis. Acta Derm. Venereol. Suppl. (Stockh.). 144:1989;13-14.
23. Gerard N.P., Garraway L.A., Eddy R.L. Jr, Shows T.B., Iijima H., Paquet J.L., Gerard C. Human substance P receptor (NK-1): organization of the gene, chromosome localization, and functional expression of cDNA clones. Biochemistry. 30:1991;10640-10646.
24. Singh L.K., Pang X., Alexacon N., Letourneau R., theoharides T.C. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: a link to neurogenic skin disorders. Brain Behav. Immun. 13:1999;225-239.
25. Liping Z, Dan C, Shuzhen Z, Shilian L. Observation of the effect of substance P on human T and B lymphocyte proliferation. Immunol Comm 1984;13:457-64.
26. Reinhold U., Wehrmann W., Kukel S., Kreysel H.W. Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities. Clin. Exp. Immunol. 79:1990;374-379.
27. Jujo K., Renz H., Abe J., Gelfand E.W., Leung D.Y. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J. Allergy Clin. Immunol. 90:1992;323-331.
28. Ho W.Z., Lai J.P., Zhu X.H., Uvaydova M., Douglas S.D. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J. Immunol. 159:1997;5654-5660.
29. Goode T., O'Connel J., Sternini C., Anton P., Wong H., O'Sullivan G.C., Collins J.K., Shanahan F. Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononuclear cells: molecular quantitation and localization. J. Immunol. 161:1998;2232-2240.
30. Lai J.P., Douglas S.D., Ho W.Z. Human lymphocytes express substance P and its receptor. J. Neuroimmunol. 86:1998;80-86.
31. Stanisz A.M., Scicchitano R., Dazin P., Bienenstock J., Payan D.G. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J. Immunol. 139:1987;749-754.
32. Lucey D.R., Novak J.M., Polonis V.R., Liu Y., Gartner S. Characterization of substance P binding to human monocytes/macrophages. Clin. Diagn. Lab. Immunol. 1:1994;330-335.
33. Wozniak A., McLennan G., Betts W.H., Murphy G.A., Scicchitano R. Activation of human neutrophils by substance P: effect on FMLP-stimulated oxidative and arachidonic acid metabolism and on antibody-dependent cell-mediated cytotoxicity. Immunology. 68:1989;359-364.
34. Shanahan F., Denburg J.A., Fox J., Bienenstock J., Befus D. Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J. Immunol. 135:1985;1331-1337.
35. Staniek V., Liebich C., Vocks E., Odia S.G., Doutremepuich J.D., Ring J., Claudy A., Schmitt D., Misery L. Modulation of cutaneous SP receptors in atopic dermatitis after UVA irradiation. Acta Derm. Venereol. 78:1998;92-94.
36. Kavelaars A., Jeurissen F., von Frijtag Drabbe Kunzel J., Herman van Roijen J., Rijkers G.T., Heijnen C.J. Substance P induces a rise in intracellular calcium concentration in human T lymphocytes in vitro: evidence of a receptor-independent mechanism. J. Neuroimmunol. 42:1993;61-70.